Previous
CHARITY TACKLING INEQUALITIES OF HEALTH WINS INTERNATIONAL AWARD
Added: (Thu Feb 28 2002)
London, 28 February 2002 - A centre established to improve the health and quality of life of local people in the Sedgefield district will be one of only ten UK charities to be awarded £25,000 at the GlaxoSmithKline (GSK) International IMPACT Awards Ceremony held in London on 28 February 2002.
The Pioneering Care Partnership (PCP) based in Newton Aycliffe, Co Durham, has been recognised by GSK for making an impact on the health of its local community. Over 17% of the local population have a limiting long-term illness and deaths from heart attacks are 44% higher than the national average. PCP has developed services to target the identified areas of need.
PCP has set up a ‘one-stop’ centre, which offers a range of community health support services, which include a hydrotherapy pool, complementary therapy suite and specialist services aimed at promoting health, independence and well-being.
The Right Honourable Derek Foster, Member of Parliament for Bishop Auckland and chairman of PCP, says: “Pioneering Care Partnership is thrilled to have won the award. It is great that the organisation, which was set up four years ago, has gained recognition so quickly. The award money will be invested in our staff and resources in order to continue the good work carried out in the Sedgefield district.”
The International IMPACT Awards, now in their fifth year, are run by GSK in partnership with the King’s Fund, a leading independent health charity. The awards reward small-to medium-sized registered charities with a proven track record in community health care. Nine other UK charities receive £25,000 while ten highly commended projects receive £1000. The scheme is running concurrently with a sister initiative in Philadelphia, USA, which is the US headquarters of GlaxoSmithKline.
Claire Hitchcock, Director, Global Community Partnership, Europe and International for GlaxoSmithKline comments: “We are delighted to support the outstanding work undertaken by these community based UK healthcare charities. The charities have demonstrated that despite the constraints of their size they can make a dramatic difference to those in need within their community.”
-Ends-
Issued by Prowse & Co on behalf of GlaxoSmithKline
For more information please contact:
Vicki Fletcher / Deborah Fields, Prowse & Co, 01372 363386 or e-mail
vicki@prowse.co.uk or deborah@prowse.co.uk
Editor’s notes
The international IMPACT Awards play a significant part in GSK’s Global Community Programme which aims to support the company’s commitment to improving the quality of human life by enabling people to so more, feel better and live longer.
The acronym IMPACT derives from the criteria that winners must have demonstrated: Innovation, Management, Partnership, Achievement, Community Focus and Targeting Need.
In the UK GSK has a continuing programme of charitable activities, which places special emphasis on scientific education and medical research. In addition, GSK seeks to fund initiatives for improving healthcare in the UK and supports a variety of projects in the visual and performing arts, as well as the environment.
As one of the world’s leading research based pharmaceutical and healthcare companies, GSK is dedicated to delivering innovative medicines and products that help millions of people around the world live longer, healthier and happier lives.
For company information visit GlaxoSmithKline at www.gsk.com
News release is available online at http://www.prowse.co.uk/newsf.html
Photographs are available on request